Ublituximab has been used in trials studying the treatment of B-cell Lymphoma, Neuromyelitis Optica, Mantle Cell Lymphoma, Non-Hodgkins Lymphoma, and Marginal Zone Lymphoma, among others.
货号（Catalog No.）
CSD00255
通用名INN
Ublituximab
纯度(Purity)
>95%
浓度( Concentration)
1mg/ml
Formulation
PBS buffer pH7.5
Source
CHO cells
内毒素(Endotoxin level)
Please contact with the lab for this information.
生物活性
产品描述(Description)
Ublituximab has been used in trials studying the treatment of B-cell Lymphoma, Neuromyelitis Optica, Mantle Cell Lymphoma, Non-Hodgkins Lymphoma, and Marginal Zone Lymphoma, among others.
别名(Alternative names)
LFB-R603, TG-1101,TGTX-1101
靶点;物种(Specificity target name;species)
MS4A1/CD20[Homo sapiens]
种类(Species)
Chimeric
受体鉴定(Receptor identification)
IgG1-kappa
化学信息
CAS
1174014-05-1
存储条件(Storage)
store at -80°C